# Jasper Therapeutics, Inc.: Form 8-K, filed May 6, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2021-05-06
- Accepted by EDGAR: May 6, 2021, 08:59 ET
- Period: 2021-05-05
- Accession: 0001213900-21-024792
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021024792/ea140401-8k_amplitude.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021024792/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021024792/ea140401-8k_amplitude.htm

Filed May 6, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-024792. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.